Marker Therapeutics Inc (MRKR)

[poods]

My guess is they will either announce a pivotal trial, expansion of multi-TAA into other solid tumor indications, or expansion of the pep mix with additional antigens. I would love to see them announce a partnership with a major BP, but may be a bit much to ask at this juncture. They may just discuss the implications of the data in more general terms. Anyway, should be very interesting.